期刊文献+

高效液相色谱法同时测定人血浆中舍曲林、喹硫平浓度 被引量:2

Determination of the concentration of sertraline and quetiapine in human plasma by HPLC with UV detection
原文传递
导出
摘要 目的:建立同时测定人血浆中舍曲林、喹硫平浓度的高效液相色谱法。方法:以Diamonsil TM C18反相柱(150 mm×4.6 mm,5μm)为色谱柱,流动相为30 mmol.L-1醋酸铵-乙腈(24∶76);流速1.0mL.min-1;柱温40°C;检测波长210 nm。以醋酸乙酯与二氯甲烷(80∶20)为提取剂。结果:舍曲林在20.0~480.0μg.L-1、喹硫平在25.0~1 000.0μg.L-1范围内,峰面积与其浓度呈良好线性关系;舍曲林、喹硫平的低、中、高3种浓度相对平均回收率大于95%,提取回收率大于70%。日内、日间RSD均低于10%(n=5)。结论:该方法灵敏、准确、简单、快速,可用于临床血药浓度监测和药动学研究。 OBJECTIVE To establlsh a method for determining the concentration of sertraline and guetiapine in human plasma by HPLC. METHODS The concentration of plasma drug was analyzed in a reverse phase HPLC system C18 column( 150mm×4.6mm,5μm): mobile phase consisted of 30 mmol·L^-1 ammonioum-acetonitrile (24:76); the flow rate was 1.0mL·min^-1; the detection wavelength was at 210 nm. Ethyl acetate and dichloromethane(80:20) was used as extracting solvent. RESUETS The calibration curves showed good Linearity range of 20.0-480.0μg·L^-1 for sertraline, 25.0~1000.0μg·L^-1 for quetiapine respectively. The average recoveries of sertraline and quetiapine in low, middle and high concentrations were over 95% respectively% the extraction recovery over 70% respectively. The intra-day and inter-day variation(RSD)was less than 10% (n= 5). The minimum detectable concentration of sertraline and quetiapine was 10. 0 μg·L^-1. CONCLUSION The method is sensitive, accurate, simple and quick, it can be used for clinical drug monitoring and pharmacokinetics studies.
出处 《中国医院药学杂志》 CAS CSCD 北大核心 2011年第17期1436-1439,共4页 Chinese Journal of Hospital Pharmacy
基金 广东省自然科学基金资助项目(编号:8151037001000001)
关键词 舍曲森 喹硫平 血药浓度 高效液相色谱法 sertraline quetiapine plasma concentration HPLC
  • 相关文献

参考文献10

二级参考文献31

  • 1张璞,李中东,焦正.第二代非典型抗精神病药——阿立哌唑[J].中国药学杂志,2005,40(3):238-240. 被引量:58
  • 2余奇,王黎青,胡哲益,郭歆,黄志壮,程泽能,赵绪元.国产盐酸舍曲林胶囊和片剂的人体药物动力学及生物等效性[J].中南药学,2005,3(2):94-97. 被引量:5
  • 3梁月竹,郑毅,张世吉,崔永华,李广泽,范萌,杨健虹,王茜.奎硫平治疗Tourette综合征对照研究[J].临床精神医学杂志,2006,16(5):292-292. 被引量:6
  • 4张朝辉,张亚林.躯体形式障碍临床研究进展[J].临床心身疾病杂志,2006,12(6):469-471. 被引量:39
  • 5沈渔村.精神病学[M].4版.北京:人民卫生出版社.2006:475-478.
  • 6Houeto JL, Gird P. Tics and Tourette syndrome: diagnosis, course and treatment principles [ J 1. Presse Med,2008,37 : 263-270.
  • 7Lavoie ME, Thibauh G, Stip E, et al. Memory and executive functions in adults with Gilles de la Tourette syndrome and chronic tic disorder [ J ]. Cogn Neuropsychiatry ,2007,12 : 165-181.
  • 8De Jonge JL, Cath DC, Van Balkom AJ. Quetiapine in patients with Tourette's disorder: an open-label, flexible-dose study [ J ]. J Clin Psychiatry ,2007,68:1148-1150.
  • 9Neves Ramos D, Van West D, Van Strien AP. Quetiapine in the treatment of the Gilles de la Tourette syndrome: A case study[ J]. Tijdschr Psychiatr,2007,49 : 263-267.
  • 10Copur M, Arpaci B, Demir T,et al. Clinical effectiveness of quetiapine in children and adolescents with Tourette's syndrome: a retrospective case-note survey [ J ]. Clin Drug Investig, 2007,27 : 123- 130.

共引文献29

同被引文献28

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部